AP
EXC icon

Antipodes Partners’s Exelon EXC Stock Holding History

Antipodes Partners’s Portfolio EXC Stock Details EXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$185M Buy
3,976,576
+213,195
+6% +$9.86M 3.4% 5
2026
Q1 		$184M Buy
3,763,381
+78,901
+2% +$3.67M 3.55% 4
2025
Q4 		$161M Buy
3,684,480
+126,948
+4% +$5.79M 3.37% 7
2025
Q3 		$160M Buy
3,557,532
+3,554,891
+134,604% +$156M 3.59% 4
2025
Q2 		$115K Buy
2,641
+1,898
+255% +$84.5K ﹤0.01% 72
2025
Q1 		$34.2K Buy
+743
New +$31.1K ﹤0.01% 88

Other funds holding EXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Antipodes Partners's EXC Position: Q2 2026 in Review

Antipodes Partners increased its Exelon (EXC) stake by 5.7% in Q2 2026, buying an estimated $9.86M and bringing the position to 3,976,576 shares worth $185M. The position accounts for 3.4% of the portfolio, ranked #5.

Antipodes Partners first reported a position in EXC in Q1 2025 and has held it in 6 quarters since. 1,288 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Antipodes Partners held 3,976,576 shares of Exelon worth $185M as of Q2 2026.
  • Antipodes Partners bought 213,195 Exelon shares in Q2 2026, an estimated $9.86M.
  • Exelon made up 3.4% of Antipodes Partners's portfolio in Q2 2026, its #5 holding.
  • Antipodes Partners first reported a position in Exelon in Q1 2025 and has held it in 6 quarters since.
  • 1,288 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.